Jan M. Van Nueten

4.0k total citations · 2 hit papers
65 papers, 3.2k citations indexed

About

Jan M. Van Nueten is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Jan M. Van Nueten has authored 65 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 19 papers in Physiology and 12 papers in Pharmacology. Recurrent topics in Jan M. Van Nueten's work include Receptor Mechanisms and Signaling (15 papers), Nitric Oxide and Endothelin Effects (13 papers) and Eicosanoids and Hypertension Pharmacology (9 papers). Jan M. Van Nueten is often cited by papers focused on Receptor Mechanisms and Signaling (15 papers), Nitric Oxide and Endothelin Effects (13 papers) and Eicosanoids and Hypertension Pharmacology (9 papers). Jan M. Van Nueten collaborates with scholars based in Belgium, United States and Netherlands. Jan M. Van Nueten's co-authors include C. J. E. Niemegeers, Pierre M. Laduron, J E Leysen, P A Janssen, Paul A. J. Janssen, R. Xhonneux, Paul M. Vanhoutte, Johan van Beek, T J Verbeuren and P M Vanhoutte and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Pharmacology and Experimental Therapeutics and Trends in Pharmacological Sciences.

In The Last Decade

Jan M. Van Nueten

62 papers receiving 2.9k citations

Hit Papers

[3H]Ketanserin (R 41 468)... 1981 2026 1996 2011 1982 1981 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan M. Van Nueten Belgium 28 1.4k 1.3k 758 407 260 65 3.2k
B. P. Richardson United Kingdom 15 1.5k 1.1× 1.4k 1.1× 786 1.0× 157 0.4× 176 0.7× 31 3.0k
R.L. Whiting Poland 34 1.5k 1.1× 2.0k 1.5× 737 1.0× 289 0.7× 91 0.3× 117 3.4k
J. Pablo Huidobro‐Toro Chile 38 1.9k 1.4× 2.2k 1.7× 1.2k 1.5× 561 1.4× 314 1.2× 182 5.0k
D P Westfall United States 29 1.2k 0.9× 1.6k 1.2× 1.2k 1.6× 579 1.4× 136 0.5× 59 3.5k
R W Fuller United Kingdom 37 1.2k 0.9× 810 0.6× 2.0k 2.6× 222 0.5× 156 0.6× 95 4.0k
Marlene L. Cohen United States 37 1.9k 1.4× 2.2k 1.7× 1.3k 1.7× 739 1.8× 585 2.3× 169 5.0k
H. Kilbinger Germany 36 2.3k 1.7× 2.4k 1.9× 911 1.2× 205 0.5× 150 0.6× 98 4.5k
J. Paul Hieble United States 32 2.0k 1.5× 2.9k 2.2× 1.1k 1.5× 473 1.2× 280 1.1× 112 5.1k
J. H. Burn United Kingdom 31 1.1k 0.8× 1.3k 1.0× 681 0.9× 806 2.0× 116 0.4× 128 3.9k
Barry A. Berkowitz United States 37 1.4k 1.0× 1.2k 0.9× 1.4k 1.9× 697 1.7× 153 0.6× 104 4.1k

Countries citing papers authored by Jan M. Van Nueten

Since Specialization
Citations

This map shows the geographic impact of Jan M. Van Nueten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan M. Van Nueten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan M. Van Nueten more than expected).

Fields of papers citing papers by Jan M. Van Nueten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan M. Van Nueten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan M. Van Nueten. The network helps show where Jan M. Van Nueten may publish in the future.

Co-authorship network of co-authors of Jan M. Van Nueten

This figure shows the co-authorship network connecting the top 25 collaborators of Jan M. Van Nueten. A scholar is included among the top collaborators of Jan M. Van Nueten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan M. Van Nueten. Jan M. Van Nueten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nueten, Jan M. Van & J. A. J. Schuurkes. (2015). Development of a Gastrointestinal Prokinetic: Pharmacology of Cisapride. PubMed. 46(1). 54–63.
2.
Heykants, J., M. Michiels, Robert Woestenborghs, et al.. (1988). Pharmacokinetic evaluation of the in vitro and in vivo pharmacological profile of the major metabolites of ketanserin in the rat.. PubMed. 38(6). 785–8. 7 indexed citations
3.
Nueten, Jan M. Van & W. J. Janssens. (1988). Cerebral Antivasoconstrictive Effects of Flunarizine. Acta Oto-Laryngologica. 105(sup460). 42–49. 5 indexed citations
4.
Nueten, Jan M. Van, W. J. Janssens, & Paul M. Vanhoutte. (1988). Calcium Antagonism and Vascular Smooth Musclea. Annals of the New York Academy of Sciences. 522(1). 234–247. 5 indexed citations
5.
Nueten, Jan M. Van, et al.. (1986). Comparative pharmacological profile of ritanserin and ketanserin. Drug Development Research. 8(1-4). 187–195. 32 indexed citations
6.
Vanhoutte, Paul M., Stephen G. Ball, Alain Berdeaux, et al.. (1986). Mechanism of action of ketanserin in hypertension. Trends in Pharmacological Sciences. 7. 58–59. 27 indexed citations
7.
Amery, Willem K., Jan M. Van Nueten, & A. Wauquier. (1984). The Pharmacological basis of migraine therapy. Pitman eBooks. 51 indexed citations
8.
Nueten, Jan M. Van & Paul M. Vanhoutte. (1984). Flunarizine. Cardiovascular Drug Reviews. 2(1). 245–266.
9.
Clerck, Fred De, Jan M. Van Nueten, & Robert S. Reneman. (1984). Platelet-vessel wall interactions: Implication of 5-hydroxytryptamine. A review. Inflammation Research. 15(5-6). 612–626. 61 indexed citations
10.
Nueten, Jan M. Van, J.E. Leysen, Fred De Clerck, & Paul M. Vanhoutte. (1984). Serotonergic Receptor Subtypes and Vascular Reactivity. Journal of Cardiovascular Pharmacology. 6. S564–S574. 64 indexed citations
11.
Clerck, Fred De & Jan M. Van Nueten. (1983). Platelet-mediated vascular contractions inhibition by flunarizine, a calcium-entry blocker. Biochemical Pharmacology. 32(5). 765–771. 33 indexed citations
12.
Nueten, Jan M. Van, J.E. Leysen, P M Vanhoutte, & P A Janssen. (1982). Serotonergic responses in vascular and non-vascular tissues.. PubMed. 256(2). 331–4. 25 indexed citations
13.
Vanhoutte, Paul M., Tony J. Verbeuren, & Jan M. Van Nueten. (1980). Effect of Lidoflazine on Systemic Arteries and Veins. Angiology. 31(9). 581–593. 8 indexed citations
14.
Nueten, Jan M. Van, et al.. (1979). Distribution of loperamide in the intestinal wall. Biochemical Pharmacology. 28(8). 1433–1434. 18 indexed citations
15.
Nueten, Jan M. Van, R. Xhonneux, & P A Janssen. (1978). Preliminary data on antiserotonin effects of oxatomide, a novel anti-allergic compound.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 232(2). 217–20. 12 indexed citations
16.
Fontaine, Jeanine, et al.. (1978). The action of physalaemin on the peristaltic reflex of guinea-pig isolated ileum. Journal of Pharmacy and Pharmacology. 30(1). 183–185. 4 indexed citations
17.
Nueten, Jan M. Van, et al.. (1978). Inhibition of dopamine receptors in the stomach: An explanation of the gastrokinetic properties of domperidone. Life Sciences. 23(5). 453–457. 67 indexed citations
18.
Nueten, Jan M. Van, Robert S. Reneman, & Paul A. J. Janssen. (1977). Specific α-adrenoceptor blocking effect of droperidol on isolated smooth muscles. European Journal of Pharmacology. 44(1). 1–8. 12 indexed citations
19.
Awouters, F., C. J. E. Niemegeers, Jan M. Van Nueten, et al.. (1977). Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediators. Cellular and Molecular Life Sciences. 33(12). 1657–1659. 42 indexed citations
20.
Nueten, Jan M. Van & Paul A. J. Janssen. (1972). Effect of cinnarizine on peripheral circulation in dogs. European Journal of Pharmacology. 17(1). 103–106. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026